Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,544 total articles
Tenaris (TS) looks set to outperform over the next 45 trading days as a $1.2B buyback program, improving technicals, and a still-fragile but positive oil services backdrop combine to tighten float and support a multiple expansion. This is a mid-term trade aimed at capturing re-rating and tactical upside while respecting event and macro risks.
Snap just reported an earnings surprise and $1.72B in Q4 revenue while producing positive free cash flow. The stock is trading near the 52-week low with an oversold RSI and elevated short interest - a recipe for a mean-reversion trade if ad demand steadies. This idea lays out a clear entry, stop and target for a long trade over the next 180 trading…
<p>Intuit (INTU) has been punished alongside the wider software cohort despite solid top-line momentum, robust cash flow and early AI monetization. The shares are down sharply from their 2025 highs and are trading at a reasonable multiple versus cash generation. This trade idea lays out a mid-term (45 trading days) buy plan with concrete entry, sto…
SoFi pulled back hard despite accelerating revenue, improving profitability and a stronger customer base. Price near $19.62 looks oversold by technicals (RSI ~30) while fundamentals show 38% revenue growth in 2025 and positive adjusted earnings. This trade idea outlines a clear entry at $19.60, a stop at $16.50 and a primary target at $28.00 over a…
Teradata is a cloud-first analytics vendor showing durable cloud ARR growth, improving cash generation and bullish technical momentum. At $33.56, the risk/reward favors a long position sized with clear stops while investors monitor ARR conversion, legacy revenue declines and an ongoing shareholder investigation.
Snowflake’s pullback has been lumped into a broader software sell-off, but its Data Cloud economics - 125% net revenue retention, $7.88B RPO and $776.7M in free cash flow - argue it will weather the transition to agent-driven workflows better than many peers. Valuation is rich, but recent technicals and clear enterprise traction around Snowflake In…
LPL Financial (LPLA) has been pulled lower with the market's recent risk-off from the tech/AI trade. The pullback leaves shares beneath key moving averages but above meaningful support and on a company with healthy ROE, strong advisor onboarding momentum and a $26.8B market cap. This trade idea lays out a mid-term buy-the-dip plan with entry at $33…
Freeport-McMoRan is benefitting from record-high copper fundamentals, improving production outlook as Grasberg phases back online, and expanding profitability. With market cap near $90B and EV/EBITDA about 10.9x, I view FCX as a buy for a 180-trading-day trade to capture re-rating and cash-flow acceleration.
Adobe’s share price has pulled back to multi-year lows and that reset opens a trade-worthy asymmetric opportunity. The company’s entrenched Creative Cloud and Experience Cloud franchises, combined with GenAI product rollout and predictable subscription revenue, give upside if execution holds. This is a tactical upgrade to Buy with a clear entry, st…
Uber sports profitable unit economics, a healthy balance sheet, and several near-term growth levers - autonomous partnerships, dealer logistics and freight expansion. I favor DoorDash for pure delivery exposure, but Uber is an actionable buy on a mid-term time frame after recent overshoot to the downside. Entry, stop and target calibrated for a 45-…
Adobe is trading near its 52-week low after a sectorwide SaaS sell-off, but fundamentals remain strong: free cash flow of $9.85B, EPS of $17.37, and a market cap near $110B imply the business can weather near-term disruption fears. This is a mid-term trade idea to buy a rebound while keeping a tight stop below key technical support.
<p>LSEG has been punished recently on headlines that large language models will commoditize financial data. That thesis misunderstands how exchanges monetize high-fidelity market content and risk services. This trade idea buys the dip: a disciplined long with clear stop and a long-term horizon to ride a valuation re-rate as investors refocus on rec…
Nebius Group (NBIS) just re-rated after beating 2025 revenue guidance and guiding for aggressive capacity expansion. The market is pricing explosive top-line growth into the stock while the company remains unprofitable and capex-hungry. For traders willing to accept execution and margin risk, there is a mid-term opportunity to buy the AI infrastruc…
Hercules Capital (HTGC) looks oversold after a sharp pullback to $15.72. The stock now yields ~10%, trades at ~1.3x book, and posts an EPS of $1.83 with a P/E around 8.5. Between strong credit covenants, recent growth in net investment income, and an upcoming dividend payment, the market’s fear of downside feels overstated. This is a mid-term trade…
MPLX offers a compelling mix of a high distribution, visible growth projects and conservative coverage that make it my preferred midstream pick versus higher-yielding peers like Western Midstream. I lay out an actionable long trade with entry at $56.83, a protective stop at $51.00 and a first target of $62.00 over a 180-trading-day horizon.
Celestica is trading like a growth hardware play but the market is pricing in near-term risk and wants clarity on 2027 demand and margins. The trade: add on weakness, hold into 2027 proof points tied to SD6300 and AI/data-center wins. Entry $275.00, stop $245.00, target $350.00; horizon: long term (180 trading days).
ASML's unique position in EUV lithography is seeing real order acceleration: a ~€39B backlog and net bookings up 48% in 2025. With a €12B buyback, a market cap of $545B and improving demand signals across AI infrastructure, the risk/reward into 2026-2028 looks favorable for a disciplined long. Entry, stop and target are provided with a 180-trading-…
Noah (NOAH) looks undervalued at roughly $815M market cap, P/E ~9.2 and P/B ~0.57 while navigating a structural compliance reset and global expansion. Technical momentum is constructive and the stock yields ~4.8%. This trade idea lays out a long entry, targets and stop, plus catalysts and risks tied to execution and regulatory clarity.
Globalstar's commercial execution is starting to show up in the numbers: highest annual revenue and a best-ever free-cash-flow year, a major capital infusion from Apple, and growing commercial partnerships. The balance sheet and FCF profile support a tactical long while competition from Starlink and elevated valuation argue for a disciplined stop. …
Duolingo is trading near its 52-week low after a year of headline-driven selling. The business generates strong free cash flow, has no net debt, and posts high returns on capital. With technicals oversold and valuation back to rational multiples, this is a tactical long with defined risk. Entry $112.90, stop $102.00, primary target $150.00 (mid-ter…
Cintas (CTAS) remains a high-quality, cash-generative business with double-digit ROE and consistent growth. Recent execution and a proposed UniFirst acquisition have been bullish catalysts, but the stock at ~$193 trades at ~41x earnings and >7x sales, leaving little margin for error. This trade idea recommends a short on strength with a mid-term ho…
Accelerant Holdings (ARX) has fallen from a $31 52-week high to near $10.67, trading like a distressed post-IPO name despite accelerating revenue and a profitable quarter as a public company. Fundamentals support a tactical long: strong revenue growth, improving unit economics, modest leverage and an enterprise value below $1B. This trade idea lays…
AppLovin's Axon AI stack and ad-monetization platform sit at the junction of mobile gaming growth and AI-driven ad effectiveness. The stock has already retraced from last year's highs, offering a mid-term swing opportunity: enter on a measured pullback, manage risk tightly, and aim for a re-rating driven by stronger monetization and improving margi…
Viking Therapeutics (VKTX) is a clinical-stage biotech focused on metabolic and endocrine disorders. Its dual GIP/GLP-1 candidate VK2735 is in phase 3 (injectable) and phase 2 (oral), positioning Viking as an under-the-radar competitor in the high-growth obesity therapeutics market. With a market cap of roughly $3.6B, a deep short-interest base, an…
Marvell is uniquely positioned at the intersection of custom AI processors and high-bandwidth optical connectivity. With a $66.6B market cap, improving margins, and recurring design-win momentum into hyperscale data centers, the stock looks actionable on a controlled pullback. This trade lays out a specific entry, stop and target with a 180-trading…
